These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 6677072)

  • 1. [Comparison of the central effect of lefadol and 3-bromophenylsuccinimide].
    Wójcik A
    Acta Pol Pharm; 1983; 40(5-6):669-79. PubMed ID: 6677072
    [No Abstract]   [Full Text] [Related]  

  • 2. [Central effect of various new carbamide and succinimide derivatives of benzoxazolone-2].
    Kolasa K; Kleinrok Z
    Acta Pol Pharm; 1981; 38(3):369-77. PubMed ID: 7315473
    [No Abstract]   [Full Text] [Related]  

  • 3. [Comparison of the anticonvulsive action of lefadol and 3-bromophenylsuccinimide and their effect on neuromediator levels in the brain].
    Wójcik A
    Acta Pol Pharm; 1983; 40(5-6):657-67. PubMed ID: 6145296
    [No Abstract]   [Full Text] [Related]  

  • 4. [Comparison of the anticonvulsant and central effects of 3-bromophenylsuccinimide and N-methylimide of 3,5-dibromophenylsuccinic acid].
    Kleinrok Z; Sieklucka-Dziuba M; Chodkowska A
    Acta Pol Pharm; 1982; 39(5-6):475-82. PubMed ID: 6927301
    [No Abstract]   [Full Text] [Related]  

  • 5. 3-Piperidynemethyl-5-chlorobenzoxazolinone-2 (PMB). Pharmacological estimation of the central action.
    Kolasa K; Kleinrok Z
    Ann Univ Mariae Curie Sklodowska Med; 1983; 38():53-62. PubMed ID: 6600082
    [No Abstract]   [Full Text] [Related]  

  • 6. [Studies on magnesium. 1. Contribution on its pharmacological effect].
    Kaemmerer K; Kietzmann M
    Zentralbl Veterinarmed A; 1984 May; 31(4):251-68. PubMed ID: 6428082
    [No Abstract]   [Full Text] [Related]  

  • 7. [Central effect of new benzoxazoline-2 and 3-hydroxybenzisoxazole derivatives].
    Kolasa K
    Acta Pol Pharm; 1979; 36(2):241-9. PubMed ID: 532680
    [No Abstract]   [Full Text] [Related]  

  • 8. [Preliminary pharmacological studies on the central action of phenyl- and piperidinemethyl derivatives of benzoxazolone-2].
    Kolasa K; Rajtar G; Kleinrok Z
    Ann Univ Mariae Curie Sklodowska Med; 1981; 36():73-81. PubMed ID: 6892098
    [No Abstract]   [Full Text] [Related]  

  • 9. [Central effect of new derivatives of ethylenediamine and imidazolidinone-2].
    Zebrowska-Lupina I; Ossowska G; Stelmasiak M; Rajtar G; Kolasa K; Chodkowska A; Kleinrok Z
    Acta Pol Pharm; 1984; 41(6):687-94. PubMed ID: 6543572
    [No Abstract]   [Full Text] [Related]  

  • 10. The effect of piracetam on the central action of ethanol in mice and rabbits.
    Czarnecka E; Stanisławska E
    Pol J Pharmacol Pharm; 1983; 35(6):451-65. PubMed ID: 6677895
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Central action of ketotifen.
    Rogóz Z; Skuza G; Sowińska H
    Pol J Pharmacol Pharm; 1981; 33(5):503-15. PubMed ID: 7335554
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship of brain ethanol metabolism to the hypnotic effect of ethanol. II: Studies in selectively bred rats and mice.
    Zimatkin SM; Liopo AV; Satanovskaya VI; Bardina And LR; Deitrich RA
    Alcohol Clin Exp Res; 2001 Jul; 25(7):982-8. PubMed ID: 11505022
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diclofensine (Ro 8-4650)--a potent inhibitor of monoamine uptake: biochemical and behavioural effects in comparison with nomifensine.
    Keller HH; Schaffner R; Carruba MO; Burkard WP; Pieri M; Bonetti EP; Scherschlicht R; Da Prada M; Haefely WE
    Adv Biochem Psychopharmacol; 1982; 31():249-63. PubMed ID: 6979165
    [No Abstract]   [Full Text] [Related]  

  • 14. Pharmacology of amezinium, a novel antihypotensive drug. VI. Effect on central nervous functions.
    Teschendorf HJ; Kretzschmar R; Kreiskott H; Weifenbach H
    Arzneimittelforschung; 1981; 31(9a):1580-8. PubMed ID: 7197973
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effects of sleep-promoting substance on sleep-waking patterns of male rats (author's transl)].
    Honda K; Inoue S
    Tokyo Ika Shika Daigaku Iyo Kizai Kenkyusho Hokoku; 1981; 15():115-23. PubMed ID: 6955900
    [No Abstract]   [Full Text] [Related]  

  • 16. [Pharmacological studies of the central effects of new ethylguanidine, imidazolidine and imidazolidinone-2 derivatives].
    Zebrowska-Lupina I; Porowska A; Stelmasiak M; Osowsska G; Juszkiewicz M; Klenk-Majewska B; Pietrasiewicz T; Kleinrok Z
    Acta Pol Pharm; 1987; 44(1):107-15. PubMed ID: 3673624
    [No Abstract]   [Full Text] [Related]  

  • 17. MK-801-induced locomotor activity in long-sleep x short-sleep recombinant inbred mouse strains: correlational analysis with low-dose ethanol and provisional quantitative trait loci.
    Zahniser NR; Negri CA; Hanania T; Gehle VM
    Alcohol Clin Exp Res; 1999 Nov; 23(11):1721-9. PubMed ID: 10591587
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Central effects of some derivatives of tetrahydrophthalimide and succinimide].
    Kleinrok Z; Jagiello-Wójtowicz E; Choma Z
    Acta Pol Pharm; 1976; 33(2):265-73. PubMed ID: 937033
    [No Abstract]   [Full Text] [Related]  

  • 19. Effects of the novel thyrotropin-releasing hormone analogue Na -((1S,2R)-2-methyl-4-oxocyclopentylcarbonyl)-L-histidyl-L-prol ina mide monohydrate on the central nervous system in mice and rats.
    Matsushita M; Yonemori F; Furukawa N; Ohta A; Toide K; Uchida I; Iwata K
    Arzneimittelforschung; 1993 Aug; 43(8):813-7. PubMed ID: 8216433
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of albumin degradation products (ADP) on the action of acetylcholine in the central nervous system.
    Buczko W; Józefów D; Ostaszewska-Puchajda B
    Acta Med Pol; 1979; 20(3):173-9. PubMed ID: 517158
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.